Quadrant Capital Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.82K | Buy |
177
+2
| +1% | +$108 | ﹤0.01% | 2191 |
|
|
2025
Q4 | $8.48K | Hold |
175
| – | – | ﹤0.01% | 2247 |
|
|
2025
Q3 | $5.36K | Buy |
+175
| New | +$4.02K | ﹤0.01% | 2310 |
|
|
2025
Q2 | – | Sell |
-175
| Closed | -$3.25K | – | 1394 |
|
|
2025
Q1 | $3.25K | Sell |
175
-110
| -39% | -$1.83K | ﹤0.01% | 2441 |
|
|
2024
Q4 | $3.77K | Sell |
285
-52
| -15% | -$1.26K | ﹤0.01% | 2374 |
|
|
2024
Q3 | $11.3K | Hold |
337
| – | – | ﹤0.01% | 2106 |
|
|
2024
Q2 | $8.45K | Hold |
337
| – | – | ﹤0.01% | 2168 |
|
|
2024
Q1 | $7.59K | Hold |
337
| – | – | ﹤0.01% | 2197 |
|
|
2023
Q4 | $7.22K | Buy |
337
+228
| +209% | +$3.93K | ﹤0.01% | 2181 |
|
|
2023
Q3 | $1.96K | Buy |
109
+93
| +581% | +$1.77K | ﹤0.01% | 2398 |
|
|
2023
Q2 | $326 | Sell |
16
-125
| -89% | -$2.53K | ﹤0.01% | 2621 |
|
|
2023
Q1 | $3.07K | Sell |
141
-261
| -65% | -$6.34K | ﹤0.01% | 2341 |
|
|
2022
Q4 | $12.5K | Buy |
402
+86
| +27% | +$2.43K | ﹤0.01% | 1848 |
|
|
2022
Q3 | $8K | Buy |
316
+117
| +59% | +$2.74K | ﹤0.01% | 1949 |
|
|
2022
Q2 | $4K | Buy |
199
+183
| +1,144% | +$4.05K | ﹤0.01% | 2011 |
|
|
2022
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 2484 |
|
|
2021
Q4 | $1K | Hold |
16
| – | – | ﹤0.01% | 2237 |
|
|
2021
Q3 | $0 | Hold |
16
| – | – | ﹤0.01% | 2490 |
|
|
2021
Q2 | $0 | Hold |
16
| – | – | ﹤0.01% | 2399 |
|
|
2021
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 2376 |
|
|
2020
Q4 | $0 | Hold |
16
| – | – | ﹤0.01% | 2286 |
|
|
2020
Q3 | $0 | Buy |
16
+3
| +23% | +$54 | ﹤0.01% | 2154 |
|
|
2020
Q2 | $0 | Sell |
13
-1,484
| -99% | -$27.1K | ﹤0.01% | 2208 |
|
|
2020
Q1 | $21K | Buy |
+1,497
| New | +$22.7K | ﹤0.01% | 1248 |
|
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
